227 related articles for article (PubMed ID: 26423803)
1. Epidermal growth factor receptor inhibition with erlotinib ameliorates anti-Thy 1.1-induced experimental glomerulonephritis.
Rintala JM; Savikko J; Rintala SE; Palin N; Koskinen PK
J Nephrol; 2016 Jun; 29(3):359-365. PubMed ID: 26423803
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.
Masuda Y; Shimizu A; Mori T; Ishiwata T; Kitamura H; Ohashi R; Ishizaki M; Asano G; Sugisaki Y; Yamanaka N
Am J Pathol; 2001 Aug; 159(2):599-608. PubMed ID: 11485918
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor-stimulating endothelial cell growth and accelerating glomerular capillary repair in experimental progressive glomerulonephritis.
Mori T; Shimizu A; Masuda Y; Fukuda Y; Yamanaka N
Nephron Exp Nephrol; 2003; 94(2):e44-54. PubMed ID: 12845230
[TBL] [Abstract][Full Text] [Related]
4. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis.
Gilbert RE; Kelly DJ; McKay T; Chadban S; Hill PA; Cooper ME; Atkins RC; Nikolic-Paterson DJ
Kidney Int; 2001 Apr; 59(4):1324-32. PubMed ID: 11260393
[TBL] [Abstract][Full Text] [Related]
5. Glomerular epithelial cell injury accelerates the progression of antibody-induced mesangial proliferative nephritis.
Shinosaki T; Notoya M; Nomura Y; Miyai I; Kobayashi T; Kurihara H
Exp Nephrol; 2002; 10(4):245-58. PubMed ID: 12097828
[TBL] [Abstract][Full Text] [Related]
6. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
[TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
8. Darbepoetin-α treatment enhances glomerular regenerative process in the Thy-1 glomerulonephritis model.
Cañadillas S; Ortega R; Estepa JC; Egea J; Gonzalez-Menchen A; Perez-Seoane C; Lopez-Andreu M; Ramirez R; Tetta C; Rodriguez M; Martin-Malo A; Aljama P
Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1278-87. PubMed ID: 20826570
[TBL] [Abstract][Full Text] [Related]
9. Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors.
Takazawa Y; Maeshima Y; Kitayama H; Yamamoto Y; Kawachi H; Shimizu F; Matsui H; Sugiyama H; Yamasaki Y; Makino H
Kidney Int; 2005 Aug; 68(2):704-22. PubMed ID: 16014048
[TBL] [Abstract][Full Text] [Related]
10. Heparin-binding EGF-like growth factor is expressed by mesangial cells and is involved in mesangial proliferation in glomerulonephritis.
Takemura T; Murata Y; Hino S; Okada M; Yanagida H; Ikeda M; Yoshioka K
J Pathol; 1999 Nov; 189(3):431-8. PubMed ID: 10547607
[TBL] [Abstract][Full Text] [Related]
11. Heparin-binding epidermal growth factor-like growth factor, an immediate-early gene for mesangial cells, is up-regulated in the Thy-1.1 model.
Polihronis M; Murphy BF; Pearse MJ; Power DA
Exp Nephrol; 1996; 4(5):271-8. PubMed ID: 8931982
[TBL] [Abstract][Full Text] [Related]
12. Counteractive effects of HGF on PDGF-induced mesangial cell proliferation in a rat model of glomerulonephritis.
Bessho K; Mizuno S; Matsumoto K; Nakamura T
Am J Physiol Renal Physiol; 2003 Jun; 284(6):F1171-80. PubMed ID: 12595276
[TBL] [Abstract][Full Text] [Related]
13. Neutralization of macrophage-stimulating protein ameliorates renal injury in anti-thy 1 glomerulonephritis.
Rampino T; Soccio G; Gregorini M; Guidetti C; Marasà M; Maggio M; Panichi V; Migliori M; Libetta C; Dal Canton A
J Am Soc Nephrol; 2007 May; 18(5):1486-96. PubMed ID: 17409315
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone mediates glomerular inflammation in experimental mesangial proliferative glomerulonephritis.
Qin D; Morita H; Inui K; Tayama H; Inoue Y; Yoshimura A
J Nephrol; 2013; 26(1):199-206. PubMed ID: 22641568
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of group IB secreted phospholipase A(2) and its M-type receptor in rat ANTI-THY-1 glomerulonephritis.
Beck S; Beck G; Ostendorf T; Floege J; Lambeau G; Nevalainen T; Radeke HH; Gurrieri S; Haas U; Thorwart B; Pfeilschifter J; Kaszkin M
Kidney Int; 2006 Oct; 70(7):1251-60. PubMed ID: 16900094
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis.
Tomita N; Kim JY; Gibbons GH; Zhang L; Kaneda Y; Stahl RA; Ogborn M; Venderville B; Morishita R; Baran D; Dzau VJ
Int J Mol Med; 2004 May; 13(5):629-36. PubMed ID: 15067361
[TBL] [Abstract][Full Text] [Related]
17. Effects of leukocytosis and macrophage activation on anti-Thy 1.1 glomerulonephritis in the rat.
Futamura A; Izumino K; Sugawara H; Nakagawa Y; Inoue H; Takata M
Scand J Urol Nephrol; 2002; 36(6):435-42. PubMed ID: 12623508
[TBL] [Abstract][Full Text] [Related]
18. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
[TBL] [Abstract][Full Text] [Related]
19. Retinoid receptor-specific agonists alleviate experimental glomerulonephritis.
Lehrke I; Schaier M; Schade K; Morath C; Waldherr R; Ritz E; Wagner J
Am J Physiol Renal Physiol; 2002 Apr; 282(4):F741-51. PubMed ID: 11880336
[TBL] [Abstract][Full Text] [Related]
20. Single application of low-dose mycophenolate mofetil-OX7-immunoliposomes ameliorates experimental mesangial proliferative glomerulonephritis.
Suana AJ; Tuffin G; Frey BM; Knudsen L; Mühlfeld C; Rödder S; Marti HP
J Pharmacol Exp Ther; 2011 May; 337(2):411-22. PubMed ID: 21349934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
